Reimportation Should Await Track/Trace Technology, HIGPA White Paper Says
Executive Summary
Providers interested in acquiring pharmaceuticals from outside the U.S. should first concentrate on advocacy for stronger anti-counterfeiting protections, the Health Industry Group Purchasing Association recommends in a product sourcing "white paper.